LA JOLLA, Calif., July 24, 2017 -- PICO Holdings, Inc. (Nasdaq: PICO) today announced that the Company will host an investor conference call and audio webcast on Wednesday, August 9th, 2017 at 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time to discuss its financial results for the second quarter ended June 30, 2017.
To participate on the call please dial 1-844-792-3731 in the U.S. or 1-412-317-5124 outside the U.S., or visit the Investors section of PICO's web site at www.picoholdings.com for a live and archived webcast.
A telephone replay of the conference call will be available through August 16, 2017 at 1-877-344-7529 (U.S.) or 1-412-317-0088 (outside the U.S.) using replay access code 10110661.
About PICO Holdings
PICO Holdings is a diversified holding company. Currently, we believe the highest potential return to shareholders is from a return of capital to shareholders. As we monetize assets, rather than reinvest the proceeds, we intend to return the capital derived therefrom, less any working capital requirements, back to shareholders through a stock repurchase program or by other means such as special dividends taking into effect liquidity requirements, debt covenants and any other contractual and legal restrictions that may exist at the time.
As of March 31, 2017, our two major investments were:
- Vidler Water Company, Inc., a water resource development business; and
- a 56.7% interest in UCP, Inc. (NYSE: UCP), a publicly-traded homebuilder and land developer in markets located in California, Washington State, North Carolina, South Carolina and Tennessee.
Contact: John T. Perri Chief Financial Officer PICO Holdings, Inc. 858-456-6022


Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
First Western Ship Transits Strait of Hormuz Since Iran War Began
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Britain Courts Anthropic Amid US Defense Department Dispute
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Apple Turns 50: From Garage Startup to AI Crossroads
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 



